DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART I
Part I: Price-Gouging An Unproven Treatment, Setting Out-of-Control Launch… Read More
Part I: Price-Gouging An Unproven Treatment, Setting Out-of-Control Launch… Read More
Part II: Pushing Debunked Innovation Rhetoric to Oppose Rx Solutions Despite… Read More
Part III: Big Pharma Maintains Price-Hiking, Patent-Gaming Business-As-Usual… Read More
Investigation Finds Big Pharma Hiked Prices More Than 250 Times On Just 12 Top… Read More
U.S. Senate Judiciary Subcommittee Hearing Tuesday Will Build on Momentum for… Read More
AbbVie CEO Headed for Capitol Hill to Answer for Indefensible Anti-Competitive… Read More
Drug Companies Repeatedly Hike Prices and Set Out-of-Control Launch Prices on… Read More
Brand Name Drug Executives Should Commit to Affordable Pricing on COVID-19… Read More
Part IV: Escalating Assault on 340B Program for Providers Serving America’s… Read More
Part III: Angling to Price-Gouge American Public on COVID-19 Treatments… Read More
Part II: Gaming the System to Undermine Competition at the Expense of American… Read More
Part I: Sticking with Price-Hiking “Business-as-Usual” During Pandemic… Read More